NO881077D0 - Kjemo-radio-immuno-konjugater. - Google Patents

Kjemo-radio-immuno-konjugater.

Info

Publication number
NO881077D0
NO881077D0 NO881077A NO881077A NO881077D0 NO 881077 D0 NO881077 D0 NO 881077D0 NO 881077 A NO881077 A NO 881077A NO 881077 A NO881077 A NO 881077A NO 881077 D0 NO881077 D0 NO 881077D0
Authority
NO
Norway
Prior art keywords
chemo
radio immuno
immuno conjugates
conjugates
radio
Prior art date
Application number
NO881077A
Other languages
English (en)
Other versions
NO881077L (no
Inventor
Joseph A Sinkule
Donald J Buchsbaum
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of NO881077D0 publication Critical patent/NO881077D0/no
Publication of NO881077L publication Critical patent/NO881077L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO881077A 1987-03-11 1988-03-10 Kjemo-radio-immuno-konjugater. NO881077L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3070087A 1987-03-11 1987-03-11

Publications (2)

Publication Number Publication Date
NO881077D0 true NO881077D0 (no) 1988-03-10
NO881077L NO881077L (no) 1988-09-12

Family

ID=21855550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881077A NO881077L (no) 1987-03-11 1988-03-10 Kjemo-radio-immuno-konjugater.

Country Status (6)

Country Link
EP (1) EP0282057A3 (no)
JP (1) JPS63301833A (no)
CN (1) CN88102026A (no)
AU (1) AU1301788A (no)
DK (1) DK134288A (no)
NO (1) NO881077L (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337598A3 (en) * 1988-02-26 1991-07-03 Georgia State University Foundation, Inc. Use of porphyrins and metalloporphyrins in the treatment of diseases caused by human immunodeficiency viruses
US5094950A (en) * 1988-06-07 1992-03-10 Nihon Medi-Physics Co., Ltd. Diethylenetriamine pentaacetic acid derivatives
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
IE63847B1 (en) * 1989-05-05 1995-06-14 Res Dev Foundation A novel antibody delivery system for biological response modifiers
WO1990015625A1 (en) * 1989-06-19 1990-12-27 Akzo N.V. RADIOIMMUNOTHERAPY USING α-PARTICLES EMISSION
US5030450A (en) * 1989-11-28 1991-07-09 Abbott Laboratories Method for inhibiting nematode infection of plants with Nematostatic trichothecene compositions
WO1991013633A1 (en) * 1990-03-12 1991-09-19 Cancer Research Campaign Technology Limited Improvements relating to immunoradiotherapy
DE19514088A1 (de) 1995-04-13 1996-10-17 Deutsches Krebsforsch Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen
WO1997014416A1 (en) * 1995-10-18 1997-04-24 Merck & Co., Inc. Conjugates useful in the treatment of benign prostatic hyperplasia
WO1998009651A1 (fr) * 1996-09-03 1998-03-12 Chugai Seiyaku Kabushiki Kaisha COMPLEXES D'ANTICORPS ANTI-INTEGRINE α3
US7736651B1 (en) 2000-11-24 2010-06-15 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
WO1999061097A2 (en) * 1998-05-26 1999-12-02 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
CN1110322C (zh) * 1999-07-21 2003-06-04 中国医学科学院医药生物技术研究所 单克隆抗体Fab'－平阳霉素偶联物及其抗肿瘤作用
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
JP2004535202A (ja) 2001-07-17 2004-11-25 リサーチ　ディベロップメント　ファンデーション アポトーシス促進性蛋白質を含む治療剤
DE102004016355A1 (de) * 2004-04-02 2005-11-03 Rösner Research GmbH & Co.KG Herstellung und Verwendung des Konjugats Methotrexat-Albumin als Mittel zur Immunosuppression bei GVHD
DE102004057196A1 (de) * 2004-11-26 2006-06-01 Rösner Research GmbH & Co.KG Verfahren zur Herstellung von Albumin-Konjugaten mit Nicht-steroidalen Antirheumatika (NSAR)
CA2666184A1 (en) * 2006-10-11 2008-04-17 Medvet Science Pty. Ltd. The use of a dna damaging agent and a ligand for the treatment of cancer
CN108226531A (zh) * 2017-12-27 2018-06-29 三诺生物传感股份有限公司 一种β2-微球蛋白检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001720A1 (en) * 1984-09-13 1986-03-27 Cytogen Corporation Antibody therapeutic agent conjugates

Also Published As

Publication number Publication date
EP0282057A2 (en) 1988-09-14
DK134288D0 (da) 1988-03-11
DK134288A (da) 1988-09-12
NO881077L (no) 1988-09-12
EP0282057A3 (en) 1990-03-07
JPS63301833A (ja) 1988-12-08
AU1301788A (en) 1988-09-15
CN88102026A (zh) 1988-09-28

Similar Documents

Publication Publication Date Title
DE3584559D1 (de) Therapeutische antikoerpermittelkonjugate.
NO890115D0 (no) Antigen-antistoff-konjugat.
NO880395D0 (no) Antigener.
DE3883899D1 (de) Geänderte antikörper.
DE3881838D1 (de) Erdbauwerke.
DE3854093D1 (de) Multibilderzeugungsgerät.
DE3881291D1 (de) Sehapparat.
DE69007311D1 (de) Konjugate.
NO881077D0 (no) Kjemo-radio-immuno-konjugater.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
NO881658D0 (no) Bifunksjonelle proteiner.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446D1 (de) Polydisilacyclobutasilazane.
FI884020A0 (fi) Tvaovaegsmottagare.
DE3869101D1 (de) Faltwerk.
DE3870513D1 (de) Tennisball.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
FI77055B (fi) Vaermegradient-inkubator.
DE3877421D1 (de) Polyamidbenzazole.
DE3879348D1 (de) Fm-cw-radargeraet.
FI871559A0 (fi) Isbrytare.
DK131588D0 (da) Immunoglobulinkonjugater
FI890655A (fi) Kombinerat handtag/kniv.
DE3874269D1 (de) Chromcarbidsinterkoerper.